447 related articles for article (PubMed ID: 38203823)
21. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
[TBL] [Abstract][Full Text] [Related]
22. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
23. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
[TBL] [Abstract][Full Text] [Related]
24. Germline ETV6 mutations and predisposition to hematological malignancies.
Feurstein S; Godley LA
Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
[TBL] [Abstract][Full Text] [Related]
25. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
26. Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Guijarro F; López-Guerra M; Morata J; Bataller A; Paz S; Cornet-Masana JM; Banús-Mulet A; Cuesta-Casanovas L; Carbó JM; Castaño-Díez S; Jiménez-Vicente C; Cortés-Bullich A; Triguero A; Martínez-Roca A; Esteban D; Gómez-Hernando M; Álamo Moreno JR; López-Oreja I; Garrote M; Risueño RM; Tonda R; Gut I; Colomer D; Díaz-Beya M; Esteve J
Blood Adv; 2023 Oct; 7(19):5799-5811. PubMed ID: 37450374
[TBL] [Abstract][Full Text] [Related]
27. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
28. Unique ethnic features of
Choi EJ; Cho YU; Hur EH; Jang S; Kim N; Park HS; Lee JH; Lee KH; Kim SH; Hwang SH; Seo EJ; Park CJ; Lee JH
Haematologica; 2022 Feb; 107(2):510-518. PubMed ID: 33626862
[TBL] [Abstract][Full Text] [Related]
29. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.
Tawana K; Brown AL; Churpek JE
Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019
[TBL] [Abstract][Full Text] [Related]
30. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.
Badar T; Chlon T
Curr Hematol Malig Rep; 2022 Oct; 17(5):113-120. PubMed ID: 35781188
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
33. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.
Duployez N; Lejeune S; Renneville A; Preudhomme C
Expert Rev Hematol; 2016 Dec; 9(12):1189-1202. PubMed ID: 27819178
[TBL] [Abstract][Full Text] [Related]
35. [Genetic predisposition to myelodysplastic syndrome/leukemia].
Hirabayashi S
Rinsho Ketsueki; 2021; 62(8):1029-1037. PubMed ID: 34497189
[TBL] [Abstract][Full Text] [Related]
36. Familial myelodysplastic syndrome/acute myeloid leukemia.
Churpek JE
Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
[TBL] [Abstract][Full Text] [Related]
37. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
[TBL] [Abstract][Full Text] [Related]
38. [Genomic aberrations in myelodysplastic syndromes and related disorders].
Makishima H
Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
[TBL] [Abstract][Full Text] [Related]
39. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]